Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
about
Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley FeverRift Valley fever virus infection in golden Syrian hamstersInflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat ModelModeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with FavipiravirHemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSsMP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamstersSingle-dose intranasal treatment with DEF201 (adenovirus vectored consensus interferon) prevents lethal disease due to Rift Valley fever virus challenge.Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.Evaluation of Fluorescence Microsphere Immunoassay for the Detection of Antibodies to Rift Valley Fever Nucleocapsid Protein and Glycoproteins.
P2860
Q21092271-1196BBB1-56BE-4EC5-9709-ECBCD2EC7965Q28543047-4B350E37-A2DB-4499-8E13-A1E06458AB0FQ33429285-9D8B9E18-3F45-47FA-9DD9-36639F7184FDQ33437038-D58FB30F-9A04-4729-B70D-21CCB828F682Q33439713-EEEB7F9A-F49A-476B-93F7-4846ACE5148FQ33705717-4808B4A2-5357-4616-8A2F-C9C0F88D90D8Q35792819-12DD9E7C-F346-47E3-813E-F78DC84DCAF9Q37673160-656CE4FA-B521-440B-B91B-AA23E46790B1Q37683496-C4E56BC8-97DC-4A00-B571-63B88316F2EFQ39251803-C9E80EC0-38A4-4B89-82C8-BC857B9AEBADQ54251506-58618EA8-8A98-4C9B-8C8F-FB77A7E2BD8E
P2860
Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Post-exposure vaccination with ...... Valley fever virus challenge.
@en
type
label
Post-exposure vaccination with ...... Valley fever virus challenge.
@en
prefLabel
Post-exposure vaccination with ...... Valley fever virus challenge.
@en
P2093
P2860
P1433
P1476
Post-exposure vaccination with ...... Valley fever virus challenge.
@en
P2093
Brian B Gowen
Dionna Scharton
Jonna B Westover
Kevin W Bailey
Ramona Skirpstunas
Tetsuro Ikegami
Zachery Vest
P2860
P304
P356
10.1016/J.ANTIVIRAL.2013.03.009
P577
2013-03-21T00:00:00Z